Genomic Analytics Startup Genoox Raises $6 Million
Genoox uses machine-learning algorithms to analyze genetic mutations
Genomic analysis startup Genoox, Ltd. announced on Thursday the completion of a $6 million funding round led by healthcare-focused venture capital fund TriVentures with participation from Inimiti Capital and Glilot Capital Partners.
For daily updates, subscribe to our newsletter by clicking here.
Genoox uses machine-learning algorithms to analyze genetic mutations. According to the company, the technology makes clinical genetic sequencing more accessible and affordable by streamlining and reducing the costs associated with detecting the connection between genetic mutations and medical conditions. Genoox’s platform also allows researchers, clinicians, and medical facilities personnel to share complex clinical data securely.
Genoox CEO Amir Trabelsi. Photo: Ofir Abe
Founded in 2014 by Israelis Amir Trabelsi and Moshe Einhorn, Genoox has offices in Palo Alto, California, New York, and Tel Aviv.
The company has raised $12 million in funding to date. In the past year, Genoox has entered partnerships with medical centers and research facilities, including the Center for Genetic Medicine Research at Children's National Medical Center and the University of Michigan.
- Startup Says It’s First to Copy Spider’s Silk Spinning Process
- "All of the World's Data Could Fit into a Single Room of Genetic Information"
- Online Genealogy Company MyHeritage Launches Campaign to Connect Adoptees and Birth Families
